American Herbal Products Association (AHPA) > News > AHPA in the News

AHPA in the News

A round-up of recent media placements featuring AHPA.

Should FDA’s Dietary Supplement GMPs Include Ingredient Suppliers?, Nutritional Outlook

Attorneys General Urge FDA to “Overhaul” Regulation of Supplements, Nutritional Outlook

New York, Indiana Attorneys General to FDA: Overhaul Supplement Regulations, Natural Products Insider

Attempts To Clean Up The Industry Could Spell Trouble For Supplement Makers, Seeking Alpha

Planning ahead is the panacea for wildcrafting supply uncertainty, experts say, NutraIngredients-USA.com

Sativex Cancer Drug Trial Poses Barrier to CBD in Supplements, Natural Products Insider

Booming Cannabis Industry's Need For Quality Control Can Be Solved, Baystreet

AHPA responds to Attorneys General letter to the FDA, Engredea News & Analysis

Dietary supplement amendments introduced to must-pass defense spending bill, Engredea News & Analysis

AHPA comments on proposed amendments to registration of food facilities, Engredea News & Analysis

AHPA comments on CA proposal to list goldenseal, aloe as 'known to cause cancer' under Prop 65, Engredea News & Analysis

Booming Cannabis Industry's Need For Quality Control Can Be Solved, MarketWatch

Strong interest in botanical ID workshop a positive sign for industry, expert says, NutraIngredients-USA

FDA:Products Containing CBD Cannot Be Sold as Dietary Supplements, Natural Products Insider

What Actions Could FDA Possibly Take on Caffeine This Year? Nutritional Outlook

OEHHA Looks To Add Two New Ingredients To Prop 65, WholeFoods Magazine

AHPA presents 'Proposition 65: What's Going On?', Engredea News & Analysis

AHPA provides expertise at World Tea Expo, Engredea News & Analysis

AHPA calls out HBO for inaccurate portrayal of DSHEA, Engredea News & Analysis


2017 Annual Fund Sponsors

           

AHPA appreciates the support of its sponsors, but does not endorse, recommend, or provide a warranty for any sponsor company, its products or services. AHPA has no responsibility for any transaction entered into with any of these companies.